Pulsenmore lands $1.27M grant, its second AI award in a month
What's the deal? PulsenmoreDealroom has a profile for this one. Try Dealroom →, an Israeli home-ultrasound company listed on Nasdaq and the Tel Aviv Stock Exchange, has secured a $1.27 million grant from the Israel Innovation AuthorityDealroom has a profile for this one. Try Dealroom → for its SmartScan AI program. The 12-month program aims to build technology that combines artificial intelligence and real-time feedback to guide pregnant women through ultrasound scans at home.
Why now? This is Pulsenmore's second AI grant from the authority within a month, following its July 2026 selection for a joint Israel Innovation Authority and Ministry of HealthDealroom has a profile for this one. Try Dealroom → program. Together, the two awards total roughly $1.6 million and support programs with a combined scope of about $3.12 million.
What's the endgame? SmartScan AI targets a core challenge in ultrasound: image quality depends on user skill. The planned system will combine position data from a new transducer to guide users until a suitable image is captured, drawing on data from more than 250,000 clinical scans and using Edge AI for fast, on-device processing.
The technology is designed to support three applications in women's health: fetal growth monitoring, visual feedback on fetal head position during delivery preparation, and follicle monitoring during fertility treatment.
What they're saying: "We are building an AI layer that will operate across the process, from ultrasound image acquisition through the clinical workflow," said founder and chief executive officer Elazar Sonnenschein. The goal, he added, is to let the platform "support a significantly greater number of home examinations without requiring a corresponding increase in clinical resources."
The signal: Non-dilutive grants like this one sit above the median for capital of its kind, giving Pulsenmore runway to reduce operator dependency and scale remote scanning — a bet that AI can turn home ultrasound into a routine part of pregnancy monitoring and fertility care.
Read more: PR Newswire
Image credit: Pulsenmore
